Inmagene launched U.S. subsidiary; Dr. Jean-Louis Saillot joined the company.
Share this article Share this article SAN DIEGO, Calif. and SHANGHAI, Feb. 2, 2021 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene"), a leading biotech company focused on immunology-related therapeutic areas, today announced the launch of its wholly-owned subsidiary in San Diego. Jean-Louis Saillot, MD has joined the company as Chief Development Officer (CDO) to oversee its global product development and clinical trial activities. "Inmagene U.S. is integral to our global innovation platform," said Dr. Jonathan Wang, Inmagene's Chairman and CEO. "Dr.'s Saillot has brought us over three ...
Source: prnewswire.com